References
- Estivill E, Bov A, Garca-Boprrenguerro D, et al. Consensus on drug treatment, definition and diagnosis for insomnia. Clin Drug Invest 2003;23:351–85
- Ustun T, Privett M, Lecrubier Y, et al. Form frequency and burden of sleep problems in general health care. Eur J Psychiatry 1996;11\(Suppl 1):5S–10S
- Wittchen HU, Krause P, Hofler M, et al. NISAS-2000: the ‘Nationwide Insomnia Screening and Awareness Study’. Prevalence and interventions in primary care. Fortschr Med Orig 2001;119:9–19
- Hajak G. Insomnia in primary care. Sleep 2000;23(Suppl 3):854–63
- Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099–107
- Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone 2003;5:5–15
- Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the National Sleep Foundation Survey. I. Sleep 1999;22\(Suppl 2):S347–S353
- Schochat T, Umphress J, Israel AJ, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999;22(Suppl 2):S359–S365
- Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97–111
- Ohayon MM, Smirne S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med 2002;3:115–20
- Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depression Anxiety 2003;18:163–76
- Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225–32
- Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425–32
- Rajput V, Bromley SM. Chronic insomnia: a practical review. Am Fam Phys 1999;60:1431–8
- Roth T. Diagnosis and management of insomnia. Clin Cornerstone 2000;2:28–38
- Buysse DJ. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 2004;59:47–51
- Idzikowski C. Impact of insomnia on health-related quality of life. Pharmacoeconomics 1996;10(Suppl 1):15–24
- Hatoum HT, Kong SX, Kania CM, et al. Insomnia: health-related quality of life and healthcare resource consumption. A study of managed-care organization enrollees. Pharmacoeconomics 1998;14:629–37
- Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(Suppl 2):S354–S358
- Schwartz S, McDowell A, Anderson W, et al. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 1999;47:313–33
- Léger D, Scheuiermaier K, Philip P, et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63: 49–55
- Léger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999;22\(Suppl 2):S394–S401
- Walsh JK, Engelhardt CL. The direct costs of insomnia in the United States for 1995. Sleep 1999;22(Suppl 2):S386–S393
- Estivill E. Behaviour of insomniacs and implications for their management. Sleep Med Rev 2002;6(Suppl 1):S3–S6
- Roehrs T, Pedrosi B, Rosenthal L, et al. Hypnotic self administration and dose escalation. Psychopharmacology 1996;127:150–4
- Martin SA, Aikens JE, Chervin RD. Towards cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004;8(1):63–72
- Quera-Salva MA, Orluc A, Goldenberg F, et al. Insomnia and use of hypnotics: study of a French population. Sleep 1991;14:386–91
- Léger D, Guilleminault C, Dreyfus JP, et al. Prevalence of insomnia in a survey of 12 778 adults in France. J Sleep Res 2000;9: 35–42
- Hollbrook AM, Crowther AR, Lotter A, et al. The role of benzodiazepines in the treatment of insomnia: a meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 2000;162:225–33
- Allaert FA, Urbinelli R. Sociodemographic profile in insomniac patients across national surveys. CNS Drugs 2004;18(Suppl 1): 3–7
- Chesson Jr A, Hartse K, Anderson WM, et al. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Stand Pract Comm Am Acad Sleep Med 2000;15:23:237–41
- Billiard M, Bentley A. Is insomnia best characterised as a symptom or a disease? Sleep Med 2004;5(Suppl 1):S35–S40
- Sateia MJ, Nowell PD. Insomnia. Lancet 2004;364:1959–73